To investigate the possibility of developing biomarkers for hcc prognosis and companion diagnostics by using advanced sequencing technologies (ngs) and the data analysis algorithms for a set of target biomarkers.
A rapid diagnostic test to predict heart failure after a myocardial infarction
Labmaster Lucia - revolutionizing blood diagnostics with rapid accurate low-cost point-of-care tests
A novel diagnostic Biosensor for ALK-targeted therapy of non-small cell lung cancer (NSCLC)
Biological self-healing agent for virgin concrete and concrete srface repair
Groundbreaking simulation of laparoscopic and robotic procedures for right hemicolectomy
Diagnostic Device for Idiopathic Parkinsonism using voice analysis
Novel chlorin e6-based medicine (photosensitiser) to efficiently treat skin cancer has been approved by rada-pharma in russia.
Therabodc aims at discovery of specific antibody fragments targeting g protein coupled receptors up regulated in tumor cells. The 2nd step is conjugating several anti-cancer drugs to the discovered antibody fragments. The 3rd is validating efficacy of combined molecules in cellular and animal model.